Detalhe da pesquisa
1.
The impact of BCG dose and revaccination on trained immunity.
Clin Immunol;
246: 109208, 2023 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36565972
2.
The Benzimidazole SPR719 Shows Promising Concentration-Dependent Activity and Synergy against Nontuberculous Mycobacteria.
Antimicrob Agents Chemother;
65(4)2021 03 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33468478
3.
An In Vitro Perspective on What Individual Antimicrobials Add to Mycobacterium avium Complex Therapies.
Antimicrob Agents Chemother;
65(8): e0273020, 2021 07 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33972258
4.
Thioridazine Is an Efflux Pump Inhibitor in Mycobacterium avium Complex but of Limited Clinical Relevance.
Antimicrob Agents Chemother;
64(7)2020 06 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32312774
5.
Inhaled tigecycline is effective against Mycobacterium abscessus in vitro and in vivo.
J Antimicrob Chemother;
75(7): 1889-1894, 2020 07 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32294173
6.
Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?
J Antimicrob Chemother;
75(3): 609-617, 2020 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31886864
7.
Auranofin Activity Exposes Thioredoxin Reductase as a Viable Drug Target in Mycobacterium abscessus.
Antimicrob Agents Chemother;
63(9)2019 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31262763
8.
Implementation of Semiautomated Antimicrobial Susceptibility Interpretation Hardware for Nontuberculous Mycobacteria May Overestimate Susceptibility.
J Clin Microbiol;
57(4)2019 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30760530
9.
A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria.
J Antimicrob Chemother;
74(4): 935-943, 2019 04 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30649327
10.
Minocycline treatment for pulmonary Mycobacterium avium complex disease based on pharmacokinetics/pharmacodynamics and Bayesian framework mathematical models.
J Antimicrob Chemother;
74(7): 1952-1961, 2019 07 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31039251
11.
Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii.
Antimicrob Agents Chemother;
62(4)2018 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29437627
12.
Minocycline Has No Clear Role in the Treatment of Mycobacterium abscessus Disease.
Antimicrob Agents Chemother;
62(10)2018 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30104268
13.
Outcomes of hypertonic saline inhalation as a treatment modality in nontuberculous mycobacterial pulmonary disease.
Eur Respir J;
54(1)2019 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31000680
14.
Nontuberculous mycobacterial pulmonary disease and Aspergillus co-infection: Bonnie and Clyde?
Eur Respir J;
54(1)2019 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30956203
15.
Genomic Insights Into the Mycobacterium kansasii Complex: An Update.
Front Microbiol;
10: 2918, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32010067
16.
Clofazimine inhalation suspension for the aerosol treatment of pulmonary nontuberculous mycobacterial infections.
J Cyst Fibros;
18(5): 714-720, 2019 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31138497
17.
The differential effect of clarithromycin and azithromycin on induction of macrolide resistance in Mycobacterium abscessus.
Future Microbiol;
14: 749-755, 2019 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31271060
18.
Stable pantothenamide bioisosteres: novel antibiotics for Gram-positive bacteria.
J Antibiot (Tokyo);
72(9): 682-692, 2019 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31171848
19.
Mycobacterium avium complex bacteria remain viable in sputum during storage and refrigeration.
Diagn Microbiol Infect Dis;
92(4): 309-310, 2018 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30025970
20.
Mycobacterium Growth Indicator Tube Time-To-Positivity Can Serve As an Early Biomarker of Treatment Response in Mycobacterium avium Complex Pulmonary Disease.
Chest;
161(2): 370-372, 2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34391756